First thyroglobulin level is a predictor of persistent disease in patients with well differentiated follicular thyroid cancer (WDTC)

被引：0
|
作者：
Zakavi, Seyed Rasoul [1 ]
Ghaffari, Azar [1 ]
Mousavi, Zohre [2 ]
机构：
[1] Mashhad Univ Med Sci, Dept Nucl Med, Mashhad, Iran
[2] Mashhad Univ Med Sci, Dept Endocrinol, Mashhad, Iran
来源：
JOURNAL OF NUCLEAR MEDICINE | 2009年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
314
引用
收藏
页数：1
相关论文
共 50 条
  • [31] High stimulated thyroglobulin on first follow up in differentiated thyroid cancer patients is really worrisome?
    Gupta, M., Jr.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S599 - S600
  • [32] The Prevalence of Undetectable Thyroglobulin and Detectable Antithyroglobulin Antibody in Patients with Well-Differentiated Thyroid Cancer.
    Gebremedhin, Efrem
    Karnchanasorn, Rudruidee
    Chiu, Ken C.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [33] Value of serum thyroglobulin measurement in patients operated on for well differentiated thyroid carcinoma
    Rüter, A
    Smeds, S
    Lennquist, S
    EUROPEAN JOURNAL OF SURGERY, 1998, 164 (09) : 665 - 671
  • [34] I-124 versus I-131 in the identification of suspected metastasis in patients well-differentiated thyroid cancer (WDTC)
    Van Nostrand, Douglas
    Moreau, S.
    Atkins, Frank
    Chennupati, S.
    Mete, Mihriye
    Burman, K.
    Wartofsky, L.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [35] The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
    Khorjekar, Gauri
    Van Nostrand, Douglas
    Vetter, Richard
    Ringel, Matthew
    Carter, Elizabeth
    Bloom, Gary
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [36] Survival rate (SR) in patients (pts) diagnosed (dx'ed) with well-differentiated thyroid cancer (WDTC) with bone metastases (BMs)
    Khorjekar, Gauri
    Van Nostrand, Douglas
    Moreau, Shari
    Atkins, Frank
    Mete, Mihriye
    Burman, Kenneth
    Wartofsky, Leonard
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [37] Can the basal serum thyroglobulin level be used to predict the recombinant human TSH-stimulated thyroglobulin level in differentiated patients with thyroid cancer?
    Jeong, Eugene
    Yoon, Joon-Kee
    Lee, Su Jin
    Soh, Euy Young
    Lee, Jeonghun
    Kim, Hyeung Kyoo
    An, Young-Sil
    MEDICINE, 2019, 98 (51)
  • [38] Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer
    Campenni, Alfredo
    Ruggeri, Rosaria Maddalena
    Siracusa, Massimiliano
    Giacoppo, Giulia
    La Torre, Flavia
    Saccomanno, Angiola
    Alibrandi, Angela
    Dionigi, Gianlorenzo
    Tuccari, Giovanni
    Baldari, Sergio
    Giovanella, Luca
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2021, 185 (03) : 397 - 404
  • [39] Postoperative Stimulated Thyroglobulin Level and Recurrence Risk Stratification in Differentiated Thyroid Cancer
    Yang Xue
    Liang Jun
    Li Tian-Jun
    Yang Ke
    Liang Dong-Quan
    Yu Zhuang
    Lin Yan-Song
    中华医学杂志英文版, 2015, 128 (08) : 1058 - 1064
  • [40] Postoperative Stimulated Thyroglobulin Level and Recurrence Risk Stratification in Differentiated Thyroid Cancer
    Yang, Xue
    Liang, Jun
    Li, Tian-Jun
    Yang, Ke
    Liang, Dong-Quan
    Yu, Zhuang
    Lin, Yan-Song
    CHINESE MEDICAL JOURNAL, 2015, 128 (08) : 1058 - 1064
12345